Finance

Beta
Lists
PKG:NYSE
Packaging Corp Of America
$224.49
+0.01%
(+0.030) 1D
$224.49
0.00% (0.00)
After hours
Closed: Jul 9, 4:00:03 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PKG...
Open
$222.89
High
$228.01
Low
$222.89
Mkt. cap
20.71B
Avg. vol.
671.77K
Volume
515.61K
Dividend
2.67%
Quarterly dividend
$1.50
Ex-dividend date
Jun 15, 2026
P/E ratio
27.29
52-wk high
$249.51
52-wk low
$189.03
EPS
$8.23
Beta
0.80
Shares outstanding
89.10M
No. of employees
17K
Open
$222.89
High
$228.01
Low
$222.89
Mkt. cap
20.71B
Avg. vol.
671.77K
Volume
515.61K
Dividend
2.67%
Quarterly dividend
$1.50
Ex-dividend date
Jun 15, 2026
P/E ratio
27.29
52-wk high
$249.51
52-wk low
$189.03
EPS
$8.23
Beta
0.80
Shares outstanding
89.10M
No. of employees
17K
News stories
From sources across the web
Profile
Packaging Corporation of America is an American manufacturing company based in Lake Forest, Illinois. The company has about 15,500 employees, with operations primarily in the United States. The CEO is Mark W. Kowlzan. Wikipedia
About Packaging Corp Of America
CEOMark W. Kowlzan
Employees16.8K
Founded1959
HeadquartersLake Forest, Illinois, United States
SectorMaterial
Websitepackagingcorp.com
Analyst ratings
Based on 8 analysts giving stock ratings to PKG in the past 3 months
Strong buy
Buy
6
Hold
2
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for PKG in the last 3 months.
Highest
Current $224.49
$272.00 (+21.16%)
Average
$256.80 (+14.39%)
Lowest
$241.00 (+7.35%)
Analyst
Recommendation
Action
Price target
Projected
Date
Detlef Winckelmann
J.P. Morgan
Buy
Maintained
$269.00
+19.8%
07/09/2026
Anthony Pettinari
Citi
Hold
Maintained
$241.00
+7.4%
07/09/2026
Gabrial Hajde
Wells Fargo
Hold
Downgraded
$246.00
+9.6%
07/08/2026
Anojja Shah
UBS
Buy
Reiterated
$272.00
+21.2%
07/06/2026
Michael Roxland
Truist Financial
Buy
Maintained
-
-
06/18/2026
Unknown Analyst
Argus Research
Buy
Maintained
-
-
05/27/2026
George Staphos
Bank of America Securities
Buy
Maintained
-
-
05/15/2026
Hillary Cacanando
Deutsche Bank
Buy
Upgraded
$256.00
+14%
05/04/2026
Next call in 14 days
Thu, Jul 23, 9:00 AM
Fiscal period
Q2 2026
EPS / Est. (USD)
- / $2.32
Revenue / Est. (USD)
- / 2.49B
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.17B
2.31B
2.36B
2.37B
Cost of goods sold
1.69B
1.79B
1.87B
1.86B
Cost of revenue
1.69B
1.79B
1.87B
1.86B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
153.20M
154.30M
165.40M
179.20M
Operating expense
162.40M
160.60M
174.10M
185.50M
Total operating expenses
1.85B
1.95B
2.04B
2.05B
Operating income
320.60M
362.80M
320.40M
318.40M
Other non operating income
-
-
-
-
EBT including unusual items
320.70M
305.20M
134.50M
219.80M
EBT excluding unusual items
307.60M
343.50M
286.50M
285.80M
Income tax expense
79.10M
78.30M
32.70M
48.90M
Effective tax rate
24.66%
25.66%
24.31%
22.25%
Other operating expenses
9.20M
6.30M
8.70M
6.30M
Net income
241.60M
226.90M
101.80M
170.90M
Net profit margin
11.13%
9.81%
4.31%
7.22%
Earnings per share
2.48
2.73
2.32
2.40
Interest and investment income
-
-
-
-
Interest expense
-13.00M
-19.30M
-33.90M
-32.60M
Net interest expenses
-13.00M
-19.30M
-33.90M
-32.60M
Depreciation and amortization charges
-
-
-
-
EBITDA
460.70M
515.40M
494.20M
493.00M
Gain or loss from assets sale
-23.50M
5.00M
44.10M
1.60M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer